Abstract
Dynamic susceptibility contrast magnetic resonance perfusion (DSC-MRP) is a non-invasive imaging technique for hemodynamic measurements. Various perfusion parameters, such as cerebral blood volume (CBV) and cerebral blood flow (CBF), can be derived from DSC-MRP, hence this non-invasive imaging protocol is widely used clinically for the diagnosis and assessment of intracranial pathologies, including tumor classification, stroke assessment, seizure detection, etc. Currently, most institutions use commercially available software to compute the perfusion parametric maps. Conventionally, the parametric maps are derived by mathematical equations which require the selection of vascular input waveforms. However, these conventional methods often have limitations, such as being time-consuming and sensitive to user input, which can lead to inconsistent results; this highlights the need for a more robust and efficient approach like deep learning. Using relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) perfusion maps generated by an FDA-approved commercial software, we trained a multi-step deep learning (DL) model. The model used each 4D MRP dataset as input, and combined the temporal features extracted from each voxel with spatial information of the brain to predict voxel-wise perfusion parameters. DL-generated rCBV and rCBF maps were evaluated qualitatively and quantitatively. An auxiliary (control) model, with similar architecture, but trained with truncated datasets that had fewer time points, was designed to explore the contribution of temporal features. Our model is based on a multistage encoder-decoder architecture that leverages a 1D convolutional neural network (CNN) as the first encoder to capture temporal information, followed by a 2D U-Net encoder-decoder network to process spatial features. This combination of encoders allows our model to effectively integrate time-varying and spatial data, generating accurate and comprehensive CBV/CBF predictions for the entire brain volume. Our model demonstrates comparable results to that of FDA-approved commercial software.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective study was conducted with the approval of the Stanford Institutional Review Board (IRB) and under a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets utilized during this study are not publicly available due to reasonable privacy and security concerns. The data is not easily redistributable to researchers other than those engaged in the Institutional Review Board-approved research collaborations with Stanford University.